*SAID ON WEDNESDAY ENTERED INTO A CONDITIONAL AGREEMENT TO SELL ITS BUSINESS TO ADDEIRA PHARMACEUTICALS AB FOR A CASH PURCHASE PRICE OF SEK 13.3 MILLION
*EXPLORES STRATEGIC ALTERNATIVES FOR THE FUTURE
*INTENDS TO PROPOSE THAT THE EXTRAORDINARY GENERAL MEETING RESOLVES TO CHANGE THE COMPANY'S COMPANY NAME TO LN FUTURE INVEST AB
((Reuters Investor Briefs; email: reutersinvestor.briefs@thomsonreuters.com))
Source Date/Time = 10-JUL-202506:29:01 GMT